Treatment of mood disorders by administration of SMR1

Details Treatment of mood disorders by administration of SMR1 Treatment of mood disorders by administration of SMR1

2008-09-09

2008-09-09

Chernyshev, Olga N (Department: 1649)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C514S016700, C514S012200, C530S300000, C530S330000, C530S317000, C530S323000

Reexamination Certificate

active

10451073

ABSTRACT:
This invention relates to the use of an agent that modulates the interaction between a SMR1 peptide and a metal-lopeptidase for the preparation of a medicament for preventing or treating a Central Nervous System disorder giving rise to a mental disorder.

REFERENCES:
patent: WO 90/03981 (1990-04-01), None
patent: 90 03981 (1990-04-01), None
patent: 98 37100 (1998-09-01), None
patent: 01 00221 (2001-01-01), None
DSM-IV, Fourth Edition. 1994, American Psychiatric Association, Washington, DC. Table of Contents, tree pages including cover.
Roques, TiPS, 2000, vol. 21, pp. 475-483.
U.S. Appl. No. 11/594,105, filed Nov. 8, 2006, Rougeot, et al.
U.S. Appl. No. 10/451,073, filed Dec. 30, 2003, US2004/0092486 Rougeot, et al.

Affiliated with

Also associated with

Rating

Treatment of mood disorders by administration of SMR1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of mood disorders by administration of SMR1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of mood disorders by administration of SMR1 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3945371